دورية أكاديمية

Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis

التفاصيل البيبلوغرافية
العنوان: Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis
المؤلفون: Piulats, J.M., Watkins, C., Costa-García, M., del Carpio, L., Piperno-Neumann, S., Rutkowski, P., Hassel, J.C., Espinosa, E., de la Cruz-Merino, L., Ochsenreither, S., Shoushtari, A.N., Orloff, M., Salama, A.K.S., Goodall, H.M., Baurain, J.-F., Nathan, P.
المصدر: In Annals of Oncology March 2024 35(3):317-326
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.11.013